APA (7th ed.) Citation

ZF, G., OG, B., LG, F., LE, O., AR, W., EM, D., . . . WR, R. (2025). Drug repurposing candidates for amyotrophic lateral sclerosis using common and rare genetic variants. Brain communications, 7(3), fcaf184. https://doi.org/10.1093/braincomms/fcaf184

Chicago Style (17th ed.) Citation

ZF, Gerring, et al. "Drug Repurposing Candidates for Amyotrophic Lateral Sclerosis Using Common and Rare Genetic Variants." Brain Communications 7, no. 3 (2025): fcaf184. https://doi.org/10.1093/braincomms/fcaf184.

MLA (9th ed.) Citation

ZF, Gerring, et al. "Drug Repurposing Candidates for Amyotrophic Lateral Sclerosis Using Common and Rare Genetic Variants." Brain Communications, vol. 7, no. 3, 2025, p. fcaf184, https://doi.org/10.1093/braincomms/fcaf184.